Subcutaneous apomorphine in patients with advanced Parkinson's disease: A dose-escalation study with randomized, double-blind, placebo-controlled crossover evaluation of a single dose - Journal of the Neurological Sciences
Apomorphine Compounded
Apomorphine - Jurox
A case series of rapid titration of subcutaneous apomorphine in Parkinson's disease | British Journal of Neuroscience Nursing
Apomorphine | C17H17NO2 - PubChem
Apomorphine sublingual film for off episodes in Parkinson's disease: a randomised, double-blind, placebo-controlled phase 3 study - The Lancet Neurology
TVM launches new, improved apomorphine injection - VetSurgeon News - VetSurgeon - VetSurgeon.org
Apomorphine subcutaneous infusion reduces dopaminergic dosage whilst maintaining motor benefits in Parkinson's disease: A prospective analysis of Thai Apomorphine Registry - MDS Abstracts
PDF) Challenges and trends in apomorphine drug delivery systems for the treatment of Parkinson's disease
An updated calculator for determining levodopa-equivalent dose | Neurological Research and Practice | Full Text
Effects of apomorphine at dose 5 and 10 mg/kg on stereotypies in trace... | Download Scientific Diagram
Toxicology review & update - VetBloom blog
Suggested protocol for initialing apomorphine theraphy. Based on... | Download Scientific Diagram
Dose-response curves for apomorphine-induced PE in D 4 R WT and KO... | Download Scientific Diagram
Safety of sublingual apomorphine film (APL-130277) for the treatment of OFF episodes in patients with Parkinson's disease: Preliminary Results from a Phase III Study - MDS Abstracts
Apomorphine - Wikipedia
Apomorphine subcutaneous infusion reduces dopaminergic dosage whilst maintaining motor benefits in Parkinson's disease: A prospective analysis of Thai Apomorphine Registry - MDS Abstracts
Apomorphine - wikidoc
Sunovion Announces U.S. FDA Approval of KYNMOBI™ (apomorphine hydrochloride) Sublingual Film for the Treatment of Parkinson's Disease OFF Episodes | Business Wire
APO-go Pen 10mg/ml Solution for Injection - Summary of Product Characteristics (SmPC) - (emc)
Apomorphine pump subjects profile | Download Scientific Diagram
Challenges and trends in apomorphine drug delivery systems for the treatment of Parkinson's disease - ScienceDirect
KYNMOBI for the Treatment of OFF episodes in Parkinson's Disease, USA
Apomorphine subcutaneous infusion in patients with Parkinson's disease with persistent motor fluctuations (TOLEDO): a multicentre, double-blind, randomised, placebo-controlled trial - The Lancet Neurology
